SA
CIPMX logo
Champlain Mid Cap Fund Advisor Class(CIPMX)
Last print unknown agoAbout this dataData status
$20.73▼-0.29 (-1.38%)Stale · unknown old

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 31.7 · very high volatility

Overview →

Champlain Mid Cap Fund Advisor Class (CIPMX)

Total Current Assets

₦17.02B

Quarterly · Period ending: · NGN

CIPMX logo

CIPMX Total Current Assets

Latest reported₦13.04B NGN
CIPMX FY Current Assets · NGN (₦2.42B → ₦13.04B)
High-resolution chart · PNG

What is total current assets?

Assets expected to be converted to cash within one year.

CIPMX total current assets history

Annual fiscal periods · NGN. Dates are reporting period ends; fiscal years can differ from calendar years.

Champlain Mid Cap Fund Advisor Class Total Current Assets — Annual fiscal periods (NGN)
Period endingTotal Current Assets (NGN)
13,037,865,000
11,266,313,000
10,516,816,000
7,661,770,000
5,878,970,000
5,545,093,000
4,263,484,000
4,252,706,000
2,913,886,000
2,576,123,000
2,554,585,000
2,423,767,000

Frequently asked questions: CIPMX total current assets

What is Champlain Mid Cap Fund Advisor Class (CIPMX)'s current total current assets?

Champlain Mid Cap Fund Advisor Class (CIPMX)'s latest reported total current assets (Quarterly) is ₦17.02B as of Mar 31, 2024. Assets expected to be converted to cash within one year.

How much historical total current assets data is available for CIPMX?

Stock Alarm Pro provides 12 dated annual fiscal periods observations for Champlain Mid Cap Fund Advisor Class (CIPMX)'s total current assets, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare CIPMX's total current assets to peers or set an alert?

You can open CIPMX's total current assets in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on CIPMX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.